AirSculpt Technologies downgraded to Market Perform from Outperform at Raymond James
The Fly

AirSculpt Technologies downgraded to Market Perform from Outperform at Raymond James

Raymond James downgraded AirSculpt Technologies to Market Perform from Outperform without a price target. AirSculpt’s Q1 results fell below expectations, with revenue and adjusted EBITDA allow below consensus estimates on a 10% year over year same-store case volume decline as management noted weakness in the low-end consumer, the analyst tells investors in a research note. While the valuation looks attractive relative to other healthcare services providers, the valuation is less relevant until there is more consistent execution and stabilization in the macro backdrop and same-store volumes, Raymond James argues.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App